Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172

INR

530.40

5.4 (1.03%)

BSENSE

Dec 17

BSE+NSE Vol: 1.54 lacs

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "530.40",
    "chg": 5.4,
    "chgp": "1.03%",
    "dir": 1,
    "prev_price": "525.00",
    "mcapval": "12,692.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE065X01017",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "1.54 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene’s Market Assessment Reflects Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-downgraded-to-sell-by-marketsmojo-amid-technical-and-financial-concerns-3760875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Indegene_mojoScore_3760875.png",
        "date": "2025-12-17 08:25:29",
        "description": "Indegene, a key player in the healthcare services sector, has recently experienced a shift in market evaluation driven by a combination of financial performance, valuation metrics, and technical indicators. This article analyses the factors influencing the current market perspective on Indegene, highlighting the interplay between its operational results, stock price movements, and broader market trends."
      },
      {
        "title": "Indegene Technical Momentum Shifts Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-faces-bearish-momentum-amid-technical-downgrade-and-market-underperformance-3760835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Indegene_technicaldot_3760835.png",
        "date": "2025-12-17 08:16:25",
        "description": "Indegene, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a more cautious market stance. Recent evaluation adjustments highlight a transition towards bearish signals across several technical indicators, coinciding with subdued price performance relative to benchmark indices."
      },
      {
        "title": "Indegene Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-upgraded-from-sell-to-hold-by-marketsmojo-on-24-nov-2025-3759935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Indegene_mojoScore_3759935.png",
        "date": "2025-12-16 10:10:19",
        "description": "Indegene, a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation, reflecting nuanced shifts across key analytical parameters. This change highlights evolving perspectives on the company’s financial health, valuation, and technical outlook amid a challenging market environment."
      },
      {
        "title": "Indegene Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-mixed-market-returns-3740490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Indegene_technicaldot_3740490.png",
        "date": "2025-12-02 08:13:35",
        "description": "Indegene, a key player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a subtle change in the stock’s price dynamics, with technical indicators such as MACD, RSI, and moving averages offering a mixed perspective on its near-term trajectory."
      },
      {
        "title": "Indegene Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-bearish-signals-despite-short-term-gains-3730388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_technicaldot_3730388.png",
        "date": "2025-11-26 08:11:20",
        "description": "Indegene, a key player in the Healthcare Services sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent evaluation adjustments highlight a transition in market assessment, with technical indicators such as MACD, RSI, and moving averages providing a mixed outlook for investors navigating this small-cap stock."
      },
      {
        "title": "Indegene’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3727986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_mojoScore_3727986.png",
        "date": "2025-11-25 09:03:10",
        "description": "Indegene, a key player in the Healthcare Services sector, has undergone a revision in its market evaluation following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite flat quarterly financial results and subdued stock returns over the past year, shifts in technical patterns and institutional interest have influenced the overall market perspective on the company."
      },
      {
        "title": "Indegene Shows Mixed Technical Signals Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-mixed-market-signals-3727740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_technicaldot_3727740.png",
        "date": "2025-11-25 08:15:46",
        "description": "Indegene, a key player in the Healthcare Services sector, is exhibiting a complex blend of technical indicators that reflect a nuanced price momentum shift. Recent market data reveals a transition in technical trends, with some signals pointing towards cautious optimism while others suggest ongoing challenges in the stock’s trajectory."
      },
      {
        "title": "How has been the historical performance of Indegene?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indegene-3726464",
        "imagepath": "",
        "date": "2025-11-24 23:31:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth Trajectory</strong></p>\n<p>Indegene’s net sales have shown a robust upward trajectory, increasing from ₹1,664.61 crores in March 2022 to ₹2,839.30 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 27.5%, reflecting strong demand and effective business expansion strategies. Total operating income mirrors this trend, as other operating income remained nil throughout the period.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) rose steadily from ₹286.92 crores in 2022 to ₹534.30 crores in 2025, indicating improved operational efficiency. When factoring in other income, operating profit (PBDIT) increased from ₹312.81 crores to ₹641.50 crores over the same period. This growth was accompanied..."
      },
      {
        "title": "Why is Indegene falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indegene-fallingrising-3687439",
        "imagepath": "",
        "date": "2025-11-11 00:24:02",
        "description": "As of 10-Nov, Indegene Ltd's stock price is currently at 518.15, reflecting a decrease of 5.0, or 0.96%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.76% during this period. Additionally, the stock has shown a significant negative performance over various time frames, with a year-to-date decline of 14.21% and a one-year drop of 24.77%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a Price to Book Value of 0.4, the company's recent quarterly results showed a decline in profit after tax, which may have contributed to the stock's downward movement. Furthermore, while institutional investors have increased their stake by 7.05%, the overall sentiment remains cautious due to the stock's underperformance compared to broader market indices.\n\nIn the broader market context, Indegene's short-term performance has..."
      }
    ],
    "total": 170,
    "sid": "10039241",
    "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "26-Nov-2025",
      "details": "Intimation of Schedule of Investors/Analysts Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "14-Nov-2025",
      "details": "Intimation of Investors/ Analysts Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Nov-2025",
      "details": "Intimation of Schedule of Investors/Analysts Meeting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene’s Market Assessment Reflects Mixed Financial and Technical Signals

2025-12-17 08:25:29

Indegene, a key player in the healthcare services sector, has recently experienced a shift in market evaluation driven by a combination of financial performance, valuation metrics, and technical indicators. This article analyses the factors influencing the current market perspective on Indegene, highlighting the interplay between its operational results, stock price movements, and broader market trends.

Indegene Technical Momentum Shifts Amid Mixed Market Returns

2025-12-17 08:16:25

Indegene, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a more cautious market stance. Recent evaluation adjustments highlight a transition towards bearish signals across several technical indicators, coinciding with subdued price performance relative to benchmark indices.

Indegene Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-12-16 10:10:19

Indegene, a small-cap player in the Healthcare Services sector, has experienced a revision in its market evaluation, reflecting nuanced shifts across key analytical parameters. This change highlights evolving perspectives on the company’s financial health, valuation, and technical outlook amid a challenging market environment.

Indegene Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:13:35

Indegene, a key player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a subtle change in the stock’s price dynamics, with technical indicators such as MACD, RSI, and moving averages offering a mixed perspective on its near-term trajectory.

Indegene Technical Momentum Shifts Amid Mixed Market Signals

2025-11-26 08:11:20

Indegene, a key player in the Healthcare Services sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent evaluation adjustments highlight a transition in market assessment, with technical indicators such as MACD, RSI, and moving averages providing a mixed outlook for investors navigating this small-cap stock.

Indegene’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts

2025-11-25 09:03:10

Indegene, a key player in the Healthcare Services sector, has undergone a revision in its market evaluation following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite flat quarterly financial results and subdued stock returns over the past year, shifts in technical patterns and institutional interest have influenced the overall market perspective on the company.

Indegene Shows Mixed Technical Signals Amidst Market Volatility

2025-11-25 08:15:46

Indegene, a key player in the Healthcare Services sector, is exhibiting a complex blend of technical indicators that reflect a nuanced price momentum shift. Recent market data reveals a transition in technical trends, with some signals pointing towards cautious optimism while others suggest ongoing challenges in the stock’s trajectory.

How has been the historical performance of Indegene?

2025-11-24 23:31:13

Revenue and Profit Growth Trajectory

Indegene’s net sales have shown a robust upward trajectory, increasing from ₹1,664.61 crores in March 2022 to ₹2,839.30 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 27.5%, reflecting strong demand and effective business expansion strategies. Total operating income mirrors this trend, as other operating income remained nil throughout the period.

Operating profit before depreciation and interest (PBDIT excluding other income) rose steadily from ₹286.92 crores in 2022 to ₹534.30 crores in 2025, indicating improved operational efficiency. When factoring in other income, operating profit (PBDIT) increased from ₹312.81 crores to ₹641.50 crores over the same period. This growth was accompanied...

Why is Indegene falling/rising?

2025-11-11 00:24:02

As of 10-Nov, Indegene Ltd's stock price is currently at 518.15, reflecting a decrease of 5.0, or 0.96%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.76% during this period. Additionally, the stock has shown a significant negative performance over various time frames, with a year-to-date decline of 14.21% and a one-year drop of 24.77%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a Price to Book Value of 0.4, the company's recent quarterly results showed a decline in profit after tax, which may have contributed to the stock's downward movement. Furthermore, while institutional investors have increased their stake by 7.05%, the overall sentiment remains cautious due to the stock's underperformance compared to broader market indices. In the broader market context, Indegene's short-term performance has...

View All News